Clarus Therapeutics Holdings, Inc.

OTCPK:CRXT.Q Stock Report

Market Cap: US$57.2k

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Clarus Therapeutics Holdings, Inc. Company Information

Clarus Therapeutics Holdings, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Clarus Therapeutics Holdings, Inc.
  • Ticker: CRXT.Q
  • Exchange: OTCPK
  • Founded: 2003
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$57.222k
  • Shares Outstanding: 52.02m
  • Website: https://clarustherapeutics.com

Number of Employees


Location

  • Clarus Therapeutics Holdings, Inc.
  • 555 Skokie Boulevard
  • Suite 340
  • Northbrook
  • Illinois
  • 60062
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CRXT.QOTCPK (Pink Sheets LLC)YesCommon StockUSUSDFeb 2021

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2023/02/10 00:00
End of Day Share Price 2023/02/09 00:00
Earnings2022/06/30
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.